Jill Marie Broadfoot insider trades: aTYR PHARMA (ATYR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jill reports to the SEC
and 1 more company
Open-market buys and sales
21 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | ATYR | ↓ Sell | 1,558 | $0.98 | $2K | Direct | Feb 4, 2026 (0d) |
| Feb 4, 2025 | ATYR | ↓ Sell | 1,254 | $3.78 | $5K | Direct | Feb 4, 2025 (0d) |
| May 31, 2024 | LIFE | ↑ Buy | 5,000 | $1.79 | $9K | Direct | Jun 3, 2024 (3d) |
| Feb 6, 2024 | LIFE | ↓ Sell | 1,590 | $1.69 | $3K | Direct | Feb 6, 2024 (0d) |
| Feb 6, 2023 | LIFE | ↓ Sell | 1,566 | $2.36 | $4K | Direct | Feb 6, 2023 (0d) |
| Jan 13, 2022 | LIFE | ↑ Buy | 1,923 | $6.75 | $13K | Direct | Jan 18, 2022 (5d) |
| Feb 9, 2021 | LIFE | ↓ Sell | 390 | $7.66 | $3K | Direct | Feb 9, 2021 (0d) |
| Jun 19, 2020 | LIFE | ↑ Buy | 1,850 | $4.22 | $8K | Direct | Jun 23, 2020 (4d) |
| Feb 7, 2020 | LIFE | ↓ Sell | 375 | $4.03 | $2K | Direct | Feb 7, 2020 (0d) |
| Sep 20, 2018 | LIFE | ↑ Buy | 64,000 | $0.83 | $53K | Direct | Sep 21, 2018 (1d) |
| Sep 14, 2018 | LIFE | ↑ Buy | 26,000 | $0.73 | $19K | Direct | Sep 18, 2018 (4d) |
| Jan 11, 2013 | VICL | ↑ Buy | 27,060 | $0.01 | $271 | Direct | Jan 15, 2013 (4d) |
| Jan 13, 2012 | VICL | ↑ Buy | 27,000 | $0.01 | $270 | Direct | Jan 18, 2012 (5d) |
| Jan 7, 2011 | VICL | ↑ Buy | 60,000 | $0.01 | $600 | Direct | Jan 11, 2011 (4d) |
| Jan 11, 2010 | VICL | ↑ Buy | 50,000 | $0.01 | $500 | Direct | Jan 12, 2010 (1d) |
| Jan 9, 2009 | VICL | ↑ Buy | 35,000 | $0.01 | $350 | Direct | Jan 12, 2009 (3d) |
| Jan 4, 2008 | VICL | ↑ Buy | 7,000 | $0.01 | $70 | Direct | Jan 7, 2008 (3d) |
| Jan 5, 2007 | VICL | ↑ Buy | 10,000 | $0.01 | $100 | Direct | Jan 8, 2007 (3d) |
| Sep 29, 2006 | VICL | ↑ Buy10b5-1 | 500 | $5.10 | $3K | Direct | Oct 2, 2006 (3d) |
| Jun 30, 2006 | VICL | ↑ Buy10b5-1 | 500 | $5.50 | $3K | Direct | Jun 30, 2006 (0d) |
| Mar 31, 2006 | VICL | ↑ Buy10b5-1 | 500 | $6.16 | $3K | Direct | Mar 31, 2006 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ATYR insiders
Open-market trades in the last 12 months
About Jill Marie Broadfoot's insider trades
Jill Marie Broadfoot is Chief Financial Officer at aTYR PHARMA (ATYR). Since Mar 31, 2006, Jill has reported 15 open-market purchases worth $112K and 6 sales worth $17K on SEC Form 4. In the last 12 months: 1 sale ($2K).
Their filings also include grants and awards (29 filings), option exercises (6 filings), shares withheld for taxes (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ATYR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.